NASDAQ:NDRA - ENDRA Life Sciences Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $2.2150 -0.12 (-5.14 %) (As of 07/16/2018 06:00 AM ET)Previous Close$2.2150Today's Range$2.10 - $2.3452-Week Range$1.55 - $5.88Volume34,561 shsAverage Volume117,767 shsMarket Capitalization$8.69 millionP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileEarnings HistoryHeadlinesOptions ChainSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging technologies, such as CT, MRI, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease or internal bleeding. It also offers the Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan. Receive NDRA News and Ratings via Email Sign-up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical SymbolNASDAQ:NDRA CUSIPN/A Webwww.endrainc.com Phone734-335-0468 Debt Debt-to-Equity RatioN/A Current Ratio4.02 Quick Ratio3.74 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$350,000.00 Price / Sales24.81 Cash FlowN/A Price / CashN/A Book Value$1.35 per share Price / Book1.64 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-5,370,000.00 Net Margins-114.33% Return on Equity-129.59% Return on Assets-118.33% Miscellaneous Employees13 Outstanding Shares3,920,000Market Cap$8.69 ENDRA Life Sciences (NASDAQ:NDRA) Frequently Asked Questions What is ENDRA Life Sciences' stock symbol? ENDRA Life Sciences trades on the NASDAQ under the ticker symbol "NDRA." How were ENDRA Life Sciences' earnings last quarter? ENDRA Life Sciences Inc (NASDAQ:NDRA) announced its earnings results on Tuesday, May, 15th. The company reported ($0.72) earnings per share for the quarter. The company earned $6.17 million during the quarter. ENDRA Life Sciences had a negative net margin of 114.33% and a negative return on equity of 129.59%. View ENDRA Life Sciences' Earnings History. When is ENDRA Life Sciences' next earnings date? ENDRA Life Sciences is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for ENDRA Life Sciences. What is the consensus analysts' recommendation for ENDRA Life Sciences? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ENDRA Life Sciences in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Who are some of ENDRA Life Sciences' key competitors? Some companies that are related to ENDRA Life Sciences include Digirad (DRAD), Nexeon Medsystems (NXNND), Dynatronics (DYNT), Aradigm (ARDM), Nexeon Medsystems (NXNN), Non-Invasive Monitoring System (NIMU), CHF Solutions (CHFS), Fc Global Realty (FCRE), Vaso (VASO), Precision Optics (PEYE), Reshape Lifesciences (RSLS), 21st North (ULGX), Escalon Medical (ESMC), Trimedyne (TMED) and Guided Therapeutics (GTHP). Who are ENDRA Life Sciences' key executives? ENDRA Life Sciences' management team includes the folowing people: Mr. Francois Michelon, Chairman & CEO (Age 52)Mr. David R. Wells, Chief Financial Officer (Age 56)Mr. Michael Thornton, Chief Technology Officer (Age 50)Dr. Jonathan Behr Ph.D., Co-Founder When did ENDRA Life Sciences IPO? (NDRA) raised $10 million in an initial public offering on Friday, February 3rd 2017. The company issued 2,000,000 shares at a price of $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities served as the underwriters for the IPO. Has ENDRA Life Sciences been receiving favorable news coverage? Press coverage about NDRA stock has trended somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. ENDRA Life Sciences earned a media sentiment score of 0.11 on Accern's scale. They also assigned media headlines about the company an impact score of 45.17 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. How do I buy shares of ENDRA Life Sciences? Shares of NDRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is ENDRA Life Sciences' stock price today? One share of NDRA stock can currently be purchased for approximately $2.2150. How big of a company is ENDRA Life Sciences? ENDRA Life Sciences has a market capitalization of $8.69 million and generates $350,000.00 in revenue each year. ENDRA Life Sciences employs 13 workers across the globe. How can I contact ENDRA Life Sciences? ENDRA Life Sciences' mailing address is 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105. The company can be reached via phone at 734-335-0468 or via email at [email protected] MarketBeat Community Rating for ENDRA Life Sciences (NASDAQ NDRA)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 35 (Vote Outperform)Underperform Votes: 37 (Vote Underperform)Total Votes: 72MarketBeat's community ratings are surveys of what our community members think about ENDRA Life Sciences and other stocks. Vote "Outperform" if you believe NDRA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NDRA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/16/2018 by MarketBeat.com StaffFeatured Article: What are Closed-End Mutual Funds?